Merck & Co. (MRK)
(Delayed Data from NYSE)
$117.17 USD
-0.06 (-0.05%)
Updated Sep 20, 2024 04:01 PM ET
After-Market: $117.31 +0.14 (0.12%) 7:58 PM ET
4-Sell of 5 4
C Value C Growth D Momentum C VGM
Industry / Sector Report
Industry : Large Cap Pharmaceuticals
Zacks Industry Rank
Top 31% (79 out of 251)Zacks Sector Rank
Top 31% (5 out of 16)Recommendations and Estimates
Company | Industry | SP500 | |
---|---|---|---|
Average Recommendation (1=Buy, 5=Sell) | 1.23 | 2.05 | 9.99 |
Current Quarter Estimate | 1.77 | 37.63 | 61.00 |
Year Ago Quarter Estimate | 2.13 | 12.41 | 54.84 |
Next Quarter Estimate | 1.95 | 38.42 | 63.00 |
Next Year Estimate | 9.70 | 173.72 | 275.00 |
Growth Rates
Company | Industry | SP500 | |
---|---|---|---|
This Year | 430.46 | 6.60 | 15.67 |
Next Year | 21.10 | 16.80 | 11.34 |
Last 5 Years | -19.90 | 2.90 | 8.10 |
Next 5 Years | 9.00 | 11.70 | NA |
Financials
Company | Industry | |
---|---|---|
Price/Earnings (TTM) | 18.00 | 22.31 |
Price/Book (MRQ) | 6.80 | 5.89 |
Price/Cash Flow (MRFY) | 38.51 | 12.20 |
Dividend Yield | 2.63% | 2.13% |
Net Profit Margin (TTM) | 21.99% | 18.86% |
Return on Equity (TTM) | 40.69% | 34.56% |
Debt to Equity (MRQ) | 0.80 | 40.19 |
MRQ = Most Recent Quarter
TTM = Trailing Twelve Months
MRFY = Most Recent Fiscal Year
Note: Company and S&P 500 ratios relating to share price calculated daily; all others calculated weekly or in accordance with company earnings announcement. Industry medians calculated weekly.